Established in 2014, the IHPI Education and Training Workgroup is charged with examining and identifying impactful, innovative, collaborative, and multidisciplinary education programs, utilizing experiential learning methods, or recommending new programs that offers services to the following groups:
- Undergraduate students
- Graduate students
- Professional and Post-doctoral students
- Mentorship and professional development opportunities for early career faculty
If you have an education and training program or concept you would like to share with the workgroup please contact Jason Wolfe, IHPI Associate Project Manager.
Caroline Richardson, M.D.
Dr. Richardson’s research focuses on physical activity and its effects on chronic diseases, web-based health interventions, diabetes, quality improvement, heart disease risk factor modification, and veterans’ health. She is the co-director of the Robert Wood Johnson Foundation Clinical Scholars Program at U-M and IHPI Clinician Scholars Program. Dr. Richardson is also a member of IHPI’s Institute Leadership Team (ILT).
Digital Education Director
Karen Farris, Ph.D., M.P.A.
Dr. Farris' research and teaching focus on social theories to examine how individuals manage medications and how pharmacists in primary care settings influence medication use. She studies individuals’ medication adherence, reasons for non-adherence, including concern and necessity beliefs, and self-reporting adverse effects.
Patricia (Pattie) Abbott, Ph.D.
Dr. Abbott’s health services research focuses on the study, modification, and implementation of Information and Communication Technologies (ICT), and the design of usable and error-mitigating Health Information Technology (HIT) in particular. She is also interested in extending her background in knowledge discovery in large datasets (data analytics) into better understanding visualization (making sense of huge collections of healthcare data in a way that provides value), human computer interaction, and user-centered design.
Amy Cohn, Ph.D.
Dr. Cohn's collaborative research projects include work in: improving the safety and efficiency of outpatient chemotherapy infusion; increasing access to specialty clinic care; building better templates for scheduling colonoscopy patients to balance access, wait times, and procedure outcomes; and developing scheduling tools for medical residents to increase their access to key training opportunities and to improve schedule quality to in turn improve quality of life, quality of patient care, and quality of educational experience. She is a member of IHPI’s Institute Leadership Team (ILT).
Nia Heard-Garris, M.D.
Dr. Heard-Garris’ health services research interests are related to immigrant, minority, and adolescent populations, and addressing social determinants of health and diversity around healthcare workforce.
Holly Jarman, Ph.D.
Professor Jarman studies the effects of market regulation, particularly cross-border regulation, on health and social policies. She explores the consequences for health that arise when markets and political jurisdictions do not match, whether those jurisdictions are nation states or subnational governments. Her publications address questions related to the relationship between tobacco control regulation and the global trading system, the regulation of cross-border health markets and product supply chains, and cross-border data exchange to promote innovative methods of public health and environmental regulation.
Lisa Prosser, Ph.D.
Dr. Prosser’s research focuses on measuring the comparative effectiveness and cost-effectiveness of childhood health interventions using methods of decision sciences and economics. Research topics include evaluating long-term health and economic outcomes for newborn screening programs using simulation modeling, measuring public values for screening programs, and developing new methods for valuing family spillover effects of childhood illness. Her research on the economic impact of influenza vaccination has been used in setting national vaccine policy for children and for prioritizing subgroups in vaccine shortage years.